Collaboration Details

Print  Close

Title of Collaborative Activity:

A5349/TBTC S31 - Rifapentine - Containing Treatment Shortening Regimens for Pulmonary Tuberculosis: A Randomized, Open-Label, Controlled Phase 3 Clinical Trial

Description of Collaborative Activity:

NIAID's AIDS Clinical Trial Group (ACTG) network and CDC's Tuberculosis Trials Consortium (TBTC) network are collaborating to enroll participants for this study (approximately half in each network). The completed trial will determine if the two proposed regimens can shorten tuberculosis treatment duration. .

Type of Collaborative Activity:

Research Initiative

Year the Collaborative Activity Originated:


NIH Participating Institutes/Centers/Office of the Director:


HHS Agency Collaborators on this Activity: